Kohsaka T, Tagawa M, Suzuki T, Ito H
National Children's Hospital, Renal Gastroenterology dept.
Nihon Rinsho. 1997 Mar;55(3):706-14.
The treatment for hemorrhagic enterocolitis due to O157 E. coli infection has been discussed to prevent its aggravation to HUS, especially in terms of the effect of antibiotics. In June, 1996, massive outbreak of the infection occurred in Sakai city, Osaka, Japan. For the purpose of the prevention against secondary infection, antibiotics therapy was employed routinely in Sakai. The epidemiological results were as follows. A total of 25996 school children probably faced infection. Among them 4671 (admission 995) children became symptomatic and 102 developed HUS, leading the ratio of HUS versus symptomatic children to 2.18% which is significantly less than the average occurrence ratio of 4.0% at the same age group nationwide. We studied the possibility of lowering the incidence of HUS by the early diagnosis and the use of antibiotics. According to our survey(86-95), we examined 193 diarrhea associated HUS cases on the effect of antibiotics. There is no meaningful change despite treatment of antibiotics during enterocolitis stage in reducing the complication of HUS, but antibiotics therapy after the onset of HUS brought the prolongation of disease course. These two results were controversial, but the main factor might be the age difference between the two study groups. As previously reported, we could'nt propose the administration of antibiotics to the infants with hemorrhagic enterocolitis due to E. coli O157.
为预防因O157大肠杆菌感染所致出血性小肠结肠炎恶化为溶血尿毒综合征(HUS),尤其是针对抗生素的作用,人们已对其治疗方法展开了讨论。1996年6月,日本大阪堺市发生了该感染的大规模暴发。为预防继发感染,堺市常规采用了抗生素治疗。流行病学结果如下:共有25996名学童可能面临感染。其中4671名(入院995名)儿童出现症状,102名发展为溶血尿毒综合征,溶血尿毒综合征患儿与有症状儿童的比例为2.18%,显著低于全国同年龄组4.0%的平均发病率。我们研究了通过早期诊断和使用抗生素降低溶血尿毒综合征发病率的可能性。根据我们的调查(86 - 95),我们检查了193例腹泻相关性溶血尿毒综合征病例使用抗生素的效果。在小肠结肠炎阶段使用抗生素治疗,在降低溶血尿毒综合征并发症方面并无显著变化,但在溶血尿毒综合征发病后使用抗生素治疗会导致病程延长。这两个结果存在争议,但主要因素可能是两个研究组之间的年龄差异。如先前报道,我们无法建议对因大肠杆菌O157所致出血性小肠结肠炎的婴儿使用抗生素。